vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.

Piedmont Realty Trust, Inc. is the larger business by last-quarter revenue ($143.3M vs $75.1M, roughly 1.9× MEDIFAST INC). On growth, Piedmont Realty Trust, Inc. posted the faster year-over-year revenue change (0.4% vs -36.9%). Over the past eight quarters, Piedmont Realty Trust, Inc.'s revenue compounded faster (0.0% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.

MED vs PDM — Head-to-Head

Bigger by revenue
PDM
PDM
1.9× larger
PDM
$143.3M
$75.1M
MED
Growing faster (revenue YoY)
PDM
PDM
+37.3% gap
PDM
0.4%
-36.9%
MED
Faster 2-yr revenue CAGR
PDM
PDM
Annualised
PDM
0.0%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
PDM
PDM
Revenue
$75.1M
$143.3M
Net Profit
$-45.0M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
-31.4%
Revenue YoY
-36.9%
0.4%
Net Profit YoY
-27.9%
EPS (diluted)
$-1.64
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
PDM
PDM
Q1 26
$143.3M
Q4 25
$75.1M
$142.9M
Q3 25
$89.4M
$139.2M
Q2 25
$105.6M
$140.3M
Q1 25
$115.7M
$142.7M
Q4 24
$119.0M
$143.2M
Q3 24
$140.2M
$139.3M
Q2 24
$168.6M
$143.3M
Net Profit
MED
MED
PDM
PDM
Q1 26
$-45.0M
Q4 25
$-43.2M
Q3 25
$-2.3M
$-13.5M
Q2 25
$2.5M
$-16.8M
Q1 25
$-772.0K
$-10.1M
Q4 24
$-30.0M
Q3 24
$1.1M
$-11.5M
Q2 24
$-8.2M
$-9.8M
Gross Margin
MED
MED
PDM
PDM
Q1 26
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Operating Margin
MED
MED
PDM
PDM
Q1 26
Q4 25
-10.4%
Q3 25
-4.6%
Q2 25
-1.0%
Q1 25
-1.1%
Q4 24
0.6%
Q3 24
1.5%
Q2 24
-4.7%
Net Margin
MED
MED
PDM
PDM
Q1 26
-31.4%
Q4 25
-30.3%
Q3 25
-2.5%
-9.7%
Q2 25
2.3%
-12.0%
Q1 25
-0.7%
-7.1%
Q4 24
-20.9%
Q3 24
0.8%
-8.3%
Q2 24
-4.8%
-6.8%
EPS (diluted)
MED
MED
PDM
PDM
Q1 26
$-0.10
Q4 25
$-1.64
$-0.34
Q3 25
$-0.21
$-0.11
Q2 25
$0.22
$-0.14
Q1 25
$-0.07
$-0.08
Q4 24
$0.08
$-0.25
Q3 24
$0.10
$-0.09
Q2 24
$-0.75
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
PDM
PDM
Cash + ST InvestmentsLiquidity on hand
$167.3M
$2.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$1.5B
Total Assets
$248.0M
$4.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
PDM
PDM
Q1 26
$2.3M
Q4 25
$167.3M
$731.0K
Q3 25
$173.5M
$3.0M
Q2 25
$162.7M
$3.3M
Q1 25
$164.6M
$2.9M
Q4 24
$162.3M
$109.6M
Q3 24
$170.0M
$133.6M
Q2 24
$163.5M
$138.5M
Total Debt
MED
MED
PDM
PDM
Q1 26
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Stockholders' Equity
MED
MED
PDM
PDM
Q1 26
$1.5B
Q4 25
$198.9M
$1.5B
Q3 25
$214.7M
$1.5B
Q2 25
$216.0M
$1.5B
Q1 25
$211.0M
$1.6B
Q4 24
$210.1M
$1.6B
Q3 24
$207.3M
$1.6B
Q2 24
$205.3M
$1.7B
Total Assets
MED
MED
PDM
PDM
Q1 26
$4.0B
Q4 25
$248.0M
$4.0B
Q3 25
$268.2M
$4.0B
Q2 25
$269.3M
$4.0B
Q1 25
$280.0M
$4.0B
Q4 24
$284.2M
$4.1B
Q3 24
$291.2M
$4.1B
Q2 24
$293.5M
$4.2B
Debt / Equity
MED
MED
PDM
PDM
Q1 26
Q4 25
1.49×
Q3 25
1.43×
Q2 25
1.41×
Q1 25
1.40×
Q4 24
1.40×
Q3 24
1.36×
Q2 24
1.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
PDM
PDM
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
110.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
PDM
PDM
Q1 26
Q4 25
$-5.3M
$140.6M
Q3 25
$12.1M
$35.8M
Q2 25
$-3.4M
$50.1M
Q1 25
$3.4M
$3.7M
Q4 24
$-4.9M
$198.1M
Q3 24
$9.1M
$42.9M
Q2 24
$13.1M
$66.8M
Free Cash Flow
MED
MED
PDM
PDM
Q1 26
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
FCF Margin
MED
MED
PDM
PDM
Q1 26
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Capex Intensity
MED
MED
PDM
PDM
Q1 26
110.3%
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Cash Conversion
MED
MED
PDM
PDM
Q1 26
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons